PHVS

PHVS

USD

Pharvaris N.V. Ordinary Shares

$21.640-0.842 (-3.746%)

Echtzeitkurs

Healthcare
Biotechnologie
Schweiz

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$22.482

Hoch

$22.482

Tief

$21.585

Volumen

0.14M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.4B

Branche

Biotechnologie

Land

Switzerland

Handelsstatistiken

Durchschnittliches Volumen

0.19M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $11.51Aktuell $21.640Hoch $26.33

Ähnliche Nachrichten

GlobeNewswire

Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting

ZUG, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living

Mehr anzeigen
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60

HC Wainwright & Co. analyst Patrick R. Trucchio initiates coverage on Pharvaris with a Buy rating and announces Price Target of $60.

Mehr anzeigen
HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60
Analyst Upgrades

B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27

B of A Securities analyst Tazeen Ahmad upgrades Pharvaris from Underperform to Neutral and raises the price target from $16 to $27.

Mehr anzeigen
B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27